US Edition
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Guggenheim
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Guggenheim
Guggenheim started coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a research report released on Tuesday, MarketBeat.com reports. The firm issued a neutral rating and a $288.00 target price on the medical research company’s stock. Several other brokerages have also weighed in on AMGN. Johnson Rice set a $294.00 price objective on shares […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
